Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Frishman

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Cardiology in Review|October 9, 2023
Istaroxime: A Novel Therapeutic Agent for Acute Heart FailureDanielle Newbury, William Frishman
American Journal of Therapeutics|December 19, 2008
Stem cell therapy for the kidney?Rachel Zubko, William Frishman
Cardiology in Review|January 11, 2014
Comprehensive review of the prognostic value of galectin-3 in heart failureElliot Coburn, William Frishman
Cardiology in Review|February 3, 2025
Investigating the Relationship Between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Blood PressureMohammed Kallash, William Frishman
Cardiology in Review|February 4, 2025
Cardiovascular SyphilisMohammed Kallash, William Frishman
Cardiology in Review|March 13, 2024
Striding Toward Cardiovascular Health: The Impact of Step Counts on Heart WellnessAnjali Goyal, William Frishman
Cardiology in Review|November 15, 2023
Cor Triatriatum: A ReviewKatherine Kilkenny, William Frishman
Cardiology in Review|February 2, 2012
Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemiaDaniel N Ricotta, William Frishman
Cardiology in Review|August 23, 2006
Nebivolol: new therapy updateSachin S Sule, William Frishman
Cardiology in Review|June 16, 2021
A Review of the Role of Type 2 Diabetes Mellitus and Sodium-Glucose Cotransporter-1 Inhibitors in Heart Failure With Preserved Ejection FractionGladys I Palaguachi, William Frishman
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Cardiology in Review|October 9, 2023
Istaroxime: A Novel Therapeutic Agent for Acute Heart FailureDanielle Newbury, William Frishman
American Journal of Therapeutics|December 19, 2008
Stem cell therapy for the kidney?Rachel Zubko, William Frishman
Cardiology in Review|January 11, 2014
Comprehensive review of the prognostic value of galectin-3 in heart failureElliot Coburn, William Frishman
Cardiology in Review|February 3, 2025
Investigating the Relationship Between Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Blood PressureMohammed Kallash, William Frishman
Cardiology in Review|February 4, 2025
Cardiovascular SyphilisMohammed Kallash, William Frishman
Cardiology in Review|March 13, 2024
Striding Toward Cardiovascular Health: The Impact of Step Counts on Heart WellnessAnjali Goyal, William Frishman
Cardiology in Review|November 15, 2023
Cor Triatriatum: A ReviewKatherine Kilkenny, William Frishman
Cardiology in Review|February 2, 2012
Mipomersen: a safe and effective antisense therapy adjunct to statins in patients with hypercholesterolemiaDaniel N Ricotta, William Frishman
Cardiology in Review|August 23, 2006
Nebivolol: new therapy updateSachin S Sule, William Frishman
Cardiology in Review|June 16, 2021
A Review of the Role of Type 2 Diabetes Mellitus and Sodium-Glucose Cotransporter-1 Inhibitors in Heart Failure With Preserved Ejection FractionGladys I Palaguachi, William Frishman
Pageof 6